Premature Ejaculation — Symptoms, Causes & Treatment | MyMedicPlus

Premature ejaculation (PE) is the most common male sexual dysfunction, defined by ejaculation within approximately 1 minute of penetration with minimal voluntary control, occurring persistently or recurrently and causing significant personal distress or interpersonal difficulty. DSM-5 diagnostic criteria require ejaculation within 1 minute of penetration on more than 75% of sexual encounters over a minimum of 6 months. It affects approximately 20–30% of men across all age groups — prevalence does not decrease significantly with age. PE is classified as lifelong (primary — present since the first sexual encounter, with a stronger neurobiological basis, shorter IELT, and poorer response to behavioural therapy alone) or acquired (secondary — develops after a period of normal ejaculatory control, often triggered by performance anxiety, erectile dysfunction, prostatitis, or relationship difficulties). The intravaginal ejaculatory latency time (IELT) — the time from vaginal penetration to ejaculation — is the primary objective measure; the median IELT in men without PE is approximately 5.4 minutes (range 0.55–44.1 minutes, IEJF study). Most men with PE report significant negative impacts on self-esteem, partner relationships, and sexual satisfaction.

Causes and contributing factors: Neurobiological (primary cause of lifelong PE): abnormal central serotonergic neurotransmission — serotonin (5-HT) has an inhibitory effect on ejaculation via 5-HT2C receptors; hypofunction of 5-HT2C or hyperfunction of 5-HT1A receptors leads to shortened ejaculatory threshold; polymorphisms in the serotonin transporter gene (5-HTTLPR) are associated with lifelong PE (genetic heritability estimated at 28%). Penile hypersensitivity: reduced sensory threshold of the glans (measured by biothesiometry) in some men with lifelong PE — contributes to rapid afferent sensory summation and ejaculatory reflex triggering. Psychological factors (particularly in acquired PE): performance anxiety (the most common psychological driver — anticipatory anxiety about ejaculating early creates a self-fulfilling cycle); depression; relationship discord; sexual trauma history; unrealistic expectations about normal sexual duration. Erectile dysfunction (ED): often present comorbidly — men with ED rush to ejaculate before losing the erection, creating secondary PE. Hyperthyroidism: thyroid hormone excess lowers ejaculatory threshold — thyroid function tests should be checked in all men with new acquired PE. Prostatitis: chronic pelvic pain syndrome / prostatitis causes lower urinary tract inflammation that alters ejaculatory reflex; prostatitis-associated PE responds to treatment of the underlying inflammation. Low testosterone: may co-exist and worsen both ED and PE.

Consistent ejaculation within approximately 1 minute of penetration (lifelong PE — IELT typically less than 60 seconds on more than 75% of occasions) or a clinically significant reduction in ejaculatory latency from previously normal (acquired PE — IELT may be 1–3 minutes, but represents a significant change). Key features as per DSM-5: persistent or recurrent ejaculation within approximately 1 minute of vaginal penetration, on more than 75% of sexual encounters, for at least 6 months, causing marked distress and interpersonal difficulty. The inability to voluntarily delay ejaculation on virtually all occasions despite wanting to is the hallmark complaint. Associated symptoms: low sexual self-confidence, sexual avoidance behaviours, relationship tension, partner dissatisfaction, and reduced frequency of sexual activity. In some cases, ejaculation occurs during foreplay or before penetration (the most severe end of the spectrum). Lifelong PE typically presents with very short IELT (under 30 seconds), present from the first sexual experience, and is consistent across partners and contexts — suggesting a neurobiological rather than psychological primary cause. Acquired PE may have variable presentation dependent on partner, setting, or anxiety level. PE Diagnostic Tool (PEDT) questionnaire — validated 5-item self-report instrument — scores above 9 are diagnostic.

Diagnosis is clinical, based on detailed sexual history using DSM-5 criteria: ejaculation within approximately 1 minute of vaginal penetration, occurring on more than 75% of sexual encounters, for at least 6 months, causing significant personal distress or interpersonal difficulty. IELT history (self-reported): clinical tool; objective IELT measurement using stopwatch by partner is used in research but not routine clinical practice. PE Diagnostic Tool (PEDT) questionnaire: 5-item validated self-report tool — scores of 9 or above indicate probable PE, 9-10 borderline. IIEF (International Index of Erectile Function) assesses comorbid erectile dysfunction — fundamental to identify as ED often drives secondary PE. Assess for: underlying causes — thyroid function tests (TSH — hyperthyroidism causes acquired PE), testosterone (hypogonadism), prostatitis history (chronic pelvic pain, urinary symptoms), medication side effects (dopaminergic agents worsen PE; tramadol paradoxically improves it). Psychological and relationship history: performance anxiety, depression, relationship quality, and sexual trauma. Partner's perspective is important when accessible — partner's sexual satisfaction and reaction to PE influences both treatment choice and outcome. In atypical presentations (sudden onset PE after years of normal function, associated with pelvic pain, haematospermia, or urinary symptoms), urological evaluation including urine culture, PSA, and urogenital ultrasound is warranted to exclude prostatitis or genitourinary pathology.

Treatment is most effective when combined — pharmacological + behavioural or pharmacological + psychological. On-demand pharmacotherapy: dapoxetine (Priligy) 30–60 mg — the only specifically licensed oral treatment for PE; a short-acting SSRI taken 1–3 hours before intercourse; prolongs IELT by approximately 3-fold; significant improvement in PE Index of Severity (PEI) and sexual satisfaction; fast onset and offset minimises daily SSRI side effects (nausea, diarrhoea, headache, dizziness in 10–20%); suitable for men who want as-needed treatment without daily medication. Daily SSRIs (off-label): paroxetine 10–40 mg/day — most effective (average 8–11-fold IELT increase — AUA 2021 guideline); sertraline 50–200 mg/day; clomipramine 25–50 mg/day; fluoxetine 20 mg/day; onset of benefit takes 1–2 weeks of daily dosing; discontinuation syndrome on abrupt cessation is a risk with paroxetine. Topical anaesthetics: EMLA cream (lidocaine 2.5% + prilocaine 2.5%) or lidocaine 9.6%/prilocaine 2.5% metered spray — applied to glans 10–20 minutes before intercourse, washed off before penetration to avoid partner numbness — prolongs IELT by 4–6 minutes on average; effective and minimal systemic absorption. Behavioural therapy: stop-start technique (Semans) — stimulate to near-ejaculation then stop completely until arousal subsides, repeat 3–4 times; squeeze technique — manual pressure applied to the frenulum or glans at the point of inevitability; sensate focus exercises with a partner. Combination therapy (topical + on-demand oral, or behavioural + pharmacological) achieves the best long-term results. If comorbid ED is present, treat with PDE5 inhibitors (sildenafil, tadalafil) first — PE often resolves once confidence in erection is restored.

Untreated PE leads to significant relationship dysfunction — partner dissatisfaction and frustration are common; partners of men with PE report higher rates of their own sexual dysfunction (arousal difficulty, orgasm problems) due to shortened intercourse duration. Avoidance of sexual intimacy develops as the psychological burden grows — sexual frequency decreases, and couples may stop having sex entirely. Reduced self-esteem, shame, and embarrassment cause social withdrawal and reluctance to seek medical help despite the condition being highly treatable. Secondary erectile dysfunction (ED) commonly develops from performance anxiety — fear of ejaculating too soon causes a secondary fear of not achieving or maintaining an erection, and the two conditions spiral together; both must be assessed and treated. Depression and clinical anxiety disorders are more prevalent in men with persistent untreated PE than the general male population. Fertility may be affected in the most severe cases (ejaculation before penetration) — preventing intravaginal sperm deposition required for natural conception. Relationship breakdown and loss of partnership intimacy beyond sexual function (emotional distance, reduced communication about intimacy) are recognised long-term consequences of untreated PE.

Open communication with a sexual partner about PE is the single most effective first step — shame and secrecy worsen both the psychological component and relationship impact; partners are almost always more understanding than men fear. Stress management (mindfulness, CBT, cognitive restructuring around performance) reduces anxiety-driven PE in acquired cases. Regular aerobic exercise improves testosterone levels, reduces anxiety, and improves sexual self-confidence. Pelvic floor muscle training (PC muscle exercises — similar to Kegel exercises but for men) has evidence for improving ejaculatory control when practised consistently for 12 weeks (pelvic physiotherapy referral can guide correct technique). Regular sexual activity — avoiding long intervals between sexual encounters reduces the hyper-sensitivity and anxiety that worsens PE after abstinence. Masturbation 1–2 hours before intercourse is a common and effective self-management strategy for acquired PE in younger men (reduces sensitivity and restores ejaculatory threshold). Avoid excessive alcohol — it disrupts the precise ejaculatory threshold regulation needed for control. Combination of behavioural techniques (stop-start, squeeze, sensate focus) with pharmacotherapy (dapoxetine or topical anaesthetic) achieves the best long-term outcomes in most published trials. Psychosexual therapy referral for relationship component, sexual trauma history, or when pharmacotherapy alone is insufficient.

See a GP, urologist, or sexual health clinic if premature ejaculation is causing you or your partner significant distress, relationship difficulties, or if self-help strategies (behavioural techniques, topical products) have not improved matters after 4-6 weeks. There is no need to feel embarrassed — PE is the most common male sexual dysfunction and is highly treatable. Ask your doctor to assess for underlying conditions that contribute to or cause PE: prostatitis (pelvic pain, urinary symptoms), erectile dysfunction (which often triggers performance anxiety leading to PE), thyroid dysfunction (hyperthyroidism can lower ejaculatory threshold), and anxiety or depression. Psychosexual therapy referral is particularly helpful for acquired PE with a clear psychological trigger or relationship component — combined medication and psychotherapy achieves better long-term outcomes than medication alone. Seek follow-up if: initial treatment (dapoxetine or topical anaesthetic) is not effective — alternative approaches exist including daily SSRI dosing or combination therapy.